146.76
0.76 (0.52%)
0.76 (0.52%)
Upgrade to Real-Time
Afterhours (Closed)
Low
78.26
High
219.75
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ligand Pharmaceuticals Incorporated | LGND | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.76 | 0.52% | 146.76 | 18:00:05 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 145.25 | 143.43 | 147.97 | 146.76 | 146.00 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 143.00 | 163.00 | 20.00 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,171 | 131,139 | $ 145.42 | $ 19,070,648 | 349,615 | 78.26 - 219.75 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:59:23 | 4 | $ 143.00 | USD |
Ligand Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 2.36B | 16.08M | 9.31M | $ 120.28M | $ -9.03M | 30.33 | -261.27 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Ligand Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LGND Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 145.16 | 153.69 | 142.16 | 148.61 | 106,411 | 1.60 | 1.1% |
| 1 Month | 163.91 | 164.79 | 139.00 | 150.71 | 135,170 | -17.15 | -10.46% |
| 3 Months | 163.28 | 219.75 | 131.01 | 169.20 | 546,899 | -16.52 | -10.12% |
| 6 Months | 92.98 | 219.75 | 78.26 | 138.92 | 464,532 | 53.78 | 57.84% |
| 1 Year | 92.13 | 219.75 | 78.26 | 125.86 | 375,243 | 54.63 | 59.3% |
| 3 Years | 168.06 | 278.62 | 57.24 | 133.22 | 429,952 | -21.30 | -12.67% |
| 5 Years | 128.73 | 278.62 | 57.24 | 130.15 | 370,515 | 18.03 | 14.01% |
Ligand Pharmaceuticals Description
| Ligand Pharmaceuticals is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material. |
